1-2 of 2
Péter Rajnics, MD PhD
Close
Sort by
Journal Articles

Efficacy and Safety of Venetoclax Combinations in t(11;14) Multiple Myeloma: Real World Data Collected from 7 Hungarian Centers

Virág Réka Szita, MD, Gábor Mikala, MD PhD, János Fábián, MD, Péter Rajnics, MD PhD, László Rejtő, MD PhD, Tamás Szendrei, MD, Hussain Alizadeh, MD PhD DSc, Laszlo Varoczy, MD PhD, Árpád Illés, MD PhD, Tamas Masszi, MD PhD, Gergely Varga, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139870
Published: 2020
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Patients (Pts) with Relapsed Multiple Myeloma: Interim Results from ASPIRE, a Randomized, Open-Label, Multicenter Phase 3 Study

A. Keith Stewart, MD, S. Vincent Rajkumar, MD, Meletios A. Dimopoulos, Tamás Masszi, MD PhD, Ivan Spicka, Prof. MD PhD, Albert Oriol, MD, Roman Hájek, MD PhD Prof. of Oncology, Laura Rosiñol, MD PhD, David S. Siegel, MD PhD, Georgi G. Mihaylov, MD PhD, Veselina Goranova-Marinova, MD PhD, Péter Rajnics, MD PhD, Aleksandr Suvorov, MD, Ruben Niesvizky, MD, Andrzej Jakubowiak, MD PhD, Jesus F. San Miguel, Heinz Ludwig, Univ. Prof. Dr., Naseem Zojwalla, MD, Margaret E. Tonda, PharmD, Biao Xing, PhD, Philippe Moreau, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 79.
https://doi.org/10.1182/blood.V124.21.79.79
Published: 2014